Nathaniel Lowe hit two home runs, James Wood and Luis Garcia Jr. hit back-to-back long balls in the fourth inning and the ...

Altimmune stock took a huge hit after its liver disease drug, pemvidutide, failed to show strong results in reducing fibrosis ...

First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with statistically significant MASH resolution without worsening of fibrosis ...

From the outset, the cast of the television series MASH was a solid ensemble of performers, led by Alan Alda, who ...

Rivus Pharmaceuticals’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the ...

Altimmune (NASDAQ:ALT) lost ~64% in the premarket on Thursday after the company announced a mixed readout from a mid-stage ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

At the heart of Monsters Are Coming is the city. This bastion of civilisation is under siege by swarms of inky black spider-like monsters, but it’s not going to take this assault lying down. No, the ...

Altimmune Inc. (NASDAQ:ALT) saw its stock tumble by 37% after releasing topline data from its Phase 2b IMPACT trial ...

The clinical-stage biopharmaceutical company reported that the trial met its primary endpoint, with up to 59.1% of participants achieving MASH resolution without worsening of fibrosis in an ...

Some TikTokers have decided to remain neutral on the situation, claiming all forms of potato are good, like the self-titled ...